Home > Cashflow Statement > NATCO PHARMA

NATCO PHARMA
Cashflow Statement

NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹2,291 Cr₹1,674 Cr₹862 Cr₹202 Cr₹580 Cr
Adjustment ₹-22 Cr₹134 Cr₹102 Cr₹124 Cr₹62 Cr
Changes In working Capital ₹-200 Cr₹-309 Cr₹63 Cr₹-231 Cr₹-213 Cr
Cash Flow after changes in Working Capital ₹2,069 Cr₹1,498 Cr₹1,027 Cr₹95 Cr₹429 Cr
Cash Flow from Operating Activities ₹1,697 Cr₹1,212 Cr₹849 Cr₹47 Cr₹299 Cr
Cash Flow from Investing Activities ₹-1,415 Cr₹-1,033 Cr₹-477 Cr₹-5.30 Cr₹-103 Cr
Cash Flow from Financing Activities ₹-211 Cr₹-247 Cr₹-363 Cr₹35 Cr₹-186 Cr
Net Cash Inflow / Outflow ₹72 Cr₹-68 Cr₹9.00 Cr₹76 Cr₹9.80 Cr
Opening Cash & Cash Equivalents ₹70 Cr₹132 Cr₹111 Cr₹26 Cr₹20 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹-22 Cr₹6.50 Cr₹12 Cr₹9.30 Cr₹-3.80 Cr
Closing Cash & Cash Equivalent ₹120 Cr₹70 Cr₹132 Cr₹111 Cr₹26 Cr

Compare Cashflow Statement of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,236.9 Cr 2.5% -1% -34% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹410,442.0 Cr 0.5% -1.5% -2.6% Stock Analytics
DIVIS LABORATORIES ₹171,878.0 Cr 5.5% -0.2% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,301.0 Cr 2.1% 2.8% 30.9% Stock Analytics
CIPLA ₹109,030.0 Cr 1.3% -7.9% -6.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,023.0 Cr 2% 4.5% 2.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.5%

-1%

-34%

SENSEX

0.5%

0.8%

7.2%


You may also like the below Video Courses